Australia's most trusted
source of pharma news
Thursday, 07 November 2024
Posted 5 November 2024 PM
Merck is getting behind Southern RNA, announcing the mRNA contract development and manufacturing organisation (CDMO) as its first-ever Emerging Biotech Grant Program winner in ANZ.
The German multinational first started the grant program in 2014 in the United States and this year expanded its reach to ANZ, Taiwan and South Korea. Merck also runs the program in Europe and China.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.